Tara C. Mitchell, MD, discusses considerations and lingering questions regarding pre- and post-operative management strategies in stage IIB/IIIC melanoma.
2025
Melanoma Patients’ Given New Hope With Ground-Breaking Clinical Trial | 10 News First
Melanoma patients with some of the worst diagnoses having seen the disease spread to their brains are tonight being given a major boost of hope, all thanks to a ground-breaking clinical trial.
New data confirms melanoma treatment having life-saving impacts | ABC NEWS
ABC News provides around the clock coverage of news events as they break in Australia and abroad. It’s news when you want it, from Australia’s most trusted news organisation.
Research helps predict which melanoma patients are most likely to respond to immunotherapy
An international team of UK and US scientists has discovered that the activity of macrophages – a type of white blood cell that engulf pathogens and cancer cells – can be used to predict whether or not a melanoma patient will respond to immunotherapy. Their findings, published in a landmark paper in JCO Oncology Advances, will help clinicians select treatments that are most likely to be effective for their patients.